| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/09/2005 | US20050124796 Mouse cytokine receptor |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124793 Novel proteins and dnas thereof |
| 06/09/2005 | US20050124792 Expression vector comprising nucleotide sequences coding G-protein coupled photoreceptor proteins for use in tools in pharmaceutical design; bioreactors and heterologous protein expression |
| 06/09/2005 | US20050124791 Ion channel |
| 06/09/2005 | US20050124790 Protein fusion comprising sequences capable of being cleaved by ubiquitin cleavage enzyme; isolating heterologous expressed, recombinant polypeptide from mixture |
| 06/09/2005 | US20050124573 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 06/09/2005 | US20050124572 Compositions and their uses directed to signal tranducers |
| 06/09/2005 | US20050124570 Using carnitine for producing genetic engineered proteins |
| 06/09/2005 | US20050124569 chemically synthesized double stranded siNA against Chemokine CXC Motif, Receptor 4 (CXCR4); modulate chemokine receptors such as CXCR4 and CXCR7A; use to inhibit viral infection (e.g., HIV), inflammatory diseases |
| 06/09/2005 | US20050124568 Moderating gene expression; mixture of small nucleic acids |
| 06/09/2005 | US20050124567 Apoptosis; controlling central nervous system disorders |
| 06/09/2005 | US20050124566 Using small nucleic acid as moderators of gene expression |
| 06/09/2005 | US20050124565 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 06/09/2005 | US20050124564 Administering vector comprising nucleic acid sequence encoding erythropoietin; controlling gene expression |
| 06/09/2005 | US20050124547 Tau-conotoxin peptides |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124070 VAC-BAC shuttle vector system |
| 06/09/2005 | US20050124069 Transfection reagents |
| 06/09/2005 | US20050124068 Hepatocellular carcinoma specific promoter and uses thereof |
| 06/09/2005 | US20050124067 For use in viral growth, identification, titering or manipulation; vaccine growth or manipulation; viral transduction of cells; or recombinant production, screening, or measurement of protein or protein interactions in vitro |
| 06/09/2005 | US20050124066 Generating and identifying shuffled plasmid variants comprising linearizing circular plasmid, introduce plasmid into host cell, cultivating cell, screening for recombined gene sequences and polypeptides |
| 06/09/2005 | US20050124064 Antimicrobial polypeptides from pseudoplectania nigrella |
| 06/09/2005 | US20050124058 System for housing/processing carrier and method for housing/processing carrier |
| 06/09/2005 | US20050124055 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
| 06/09/2005 | US20050124054 Novel proteins and methods for producing the proteins |
| 06/09/2005 | US20050124049 Transgenic gramnegative bacteria for use as bioreactor in production of cysteine |
| 06/09/2005 | US20050124047 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated acek gene |
| 06/09/2005 | US20050124043 Chemotactic cytokine for use in diagnosis, prevention and treatment of tumors |
| 06/09/2005 | US20050124042 Method for expression of heterologous proteins in yeast |
| 06/09/2005 | US20050124041 Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
| 06/09/2005 | US20050124040 Which produces N-alkyl-L-alanine from pyruvic acid and alkylamine or dialkylamine using NADPH and/or NADH as coenzyme; biosynthesis |
| 06/09/2005 | US20050124039 Mixing cationic lipid with a polynucleotide, coding for antigenic determinant, thereby forming a cationic lipid-polynucleotide complex; administering complex to animal for eliciting an immune response |
| 06/09/2005 | US20050124038 Transfection of cartilage and matrices thereof in vitro |
| 06/09/2005 | US20050124037 Nucleic acid molecules encoding proteins which impart the adhesion of Neisseria cells to human cells |
| 06/09/2005 | US20050124036 Method for producing recombinant proteins in micro-organisms |
| 06/09/2005 | US20050124035 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and methd for producing alpha-L-aspartyl-l-phenylalanine-alpha-methyl esther |
| 06/09/2005 | US20050124033 For the production of carotenoid compounds through the down-regulation of various genes in the carotenoid biosynthetic pathway |
| 06/09/2005 | US20050124032 Using ethyl methanesulfonate mutagenesis to generate yeast cells which overexpress/produce astaxanthins; food supplements; food coloring |
| 06/09/2005 | US20050124031 Biosyntheticse genes of blakeslea trispora beta-carotene that code for lycopene cyclase/phytoene synthase (carrp) and phytoene dehydrogenase (carb) |
| 06/09/2005 | US20050124030 Transforming corynebacterium with expression vector comprising nucleotide sequences coding antisense sequences which reduce expression of cytochrome oxidase and select for accumulation of riboflavin |
| 06/09/2005 | US20050124029 Process for the preparation of a betha- lactam antibiotic with mutated penicillin acylase |
| 06/09/2005 | US20050124010 Analyzing differences in molecular mass distinguishable by mass spectrographic analysis, fragmenting, separating via chromatography, then inputting to database; for producing transgenic microbes/plants having activatable traits |
| 06/09/2005 | US20050124007 Human mesencephalon cell lines and methods of use therefor |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050124003 Using immunoaffinity selection to isolate and propagate pluripotent stem cell populations from fetal developmental tissues; cell replacement therapies |
| 06/09/2005 | US20050123994 Composition for protecting proteins degradation comprising small heat shock proteins (sHSPs) and method of two-dimensional gel electrophoresis using the sHSPs |
| 06/09/2005 | US20050123991 Nucleotide sequences coding hydrolase capable of resolving enantiomeric mixtures of alcohol or ester substrates; for use in regio-and stereoselective biotransformations |
| 06/09/2005 | US20050123989 Producing 2-keto-L-gluconic acid (2-KGA) from L-sorbose or D-sorbitol utilizing microorganism comprising recombinant sequences coding cytochrome oxidase; bioreactors |
| 06/09/2005 | US20050123988 Contain a target binding domain biased towards the target sequence such that the domain forms a more stable hybrid with the target sequence than with the target closing domain under the same conditions, a target closing domain, and a joining region that facilitates the formation of a closed torch |
| 06/09/2005 | US20050123986 Using aminated polypropylene as component in generating solid supports for detection preferential biopolymers; microarray biosynthesis |
| 06/09/2005 | US20050123984 Methods for generating cellulases |
| 06/09/2005 | US20050123980 Using primer specific polymerase chain reaction to characterize preferential regions of genome; functional genomic fingerprinting |
| 06/09/2005 | US20050123978 Knockout mouse for the tumor suppressor gene ANX7 |
| 06/09/2005 | US20050123972 Such as ligand binding and screening assays and signalling assays; chimeric chemokine receptor can also form a component of a chemokine receptor modulator design program |
| 06/09/2005 | US20050123965 Isolating preferential nucleotide sequences from mixture comprising mixing an RNA-containing material with a predetermined concentration of chaotropic agent, organic solvent and nucleic acid-binding solid phase support, separating solid and liquid phases, eluting and recovering RNA |
| 06/09/2005 | US20050123964 G-protein coupled receptors high-throughput functional assay |
| 06/09/2005 | US20050123961 Human G-protein coupled receptors |
| 06/09/2005 | US20050123958 Using single stranded nuclease digestion to remove mishybridized regions between oligonucleotide probes and target nucleotide sequences; enhancing reporter function of diagnostic probes |
| 06/09/2005 | US20050123955 Novel human thrombospondin-like proteins and polynucleotides encoding the same |
| 06/09/2005 | US20050123954 Using bacterial specific probes to detect presence of microbes in food and water; food safety and quality control |
| 06/09/2005 | US20050123953 Novel human kinase and polynucleotides encoding the same |
| 06/09/2005 | US20050123951 Polynucleotide microarray including two or more groups of probe polynucleotides immobilized on substrate according to melting temperature and method for detecting target polynucleotides using the same |
| 06/09/2005 | US20050123942 Nucleotide sequences coding kinase for use as tool in diagnosis, prevention and treatment of restenosis, cell proliferative and ischemic disorders |
| 06/09/2005 | US20050123941 Expression vector comprising nucleotide sequences coding polypeptide associated with fructo-oligosaccharide proteins for use in prevention or treatment of infections, diarrheal, cell proliferative and immune system disorders |
| 06/09/2005 | US20050123940 Mutant Family B DNA polymerase for use as replicative tool in genetic engineering |
| 06/09/2005 | US20050123933 Assay systems, kits and methods for detecting microorganisms |
| 06/09/2005 | US20050123927 Constructing complimentary DNA libraries for use in gene expression analysis |
| 06/09/2005 | US20050123926 In vitro process for producing multiple nucleic acid copies |
| 06/09/2005 | US20050123925 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2005 | US20050123919 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy |
| 06/09/2005 | US20050123918 Mhc class I peptide epitopes from the human 5t4 tumor-associated antigen |
| 06/09/2005 | US20050123914 Method of isolating cells and uses thereof |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123909 Compositions and methods for treating cells having double minute dna |
| 06/09/2005 | US20050123905 Relicating preferential nucleotide sequences using mixture comprising polymerase-amplified nucleic acid having a 5' overhang, a vector having a 3' overhang and an antibody that binds polymerase; improving exogenous gene expression |
| 06/09/2005 | US20050123900 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
| 06/09/2005 | US20050123898 Viral propagation mixture comprising expression vector, packaging cell line and donor plasmid for use in insertion, amplification, propagation and expression of heterologous gene sequences |
| 06/09/2005 | US20050123896 Drug screening a test agent, promoter silencing agents for treatment of cancer; histone deacetylase (HDAC) inhibitors like sodium butyrate and trichostatin A; modulate gene expression; bioassay, analysis; testing kits |
| 06/09/2005 | US20050123624 Manganese ion regulation of reverse transcriptase activity and methods of modulating same |
| 06/09/2005 | US20050123600 Compositions and methods for drug delivery using pH sensitive molecules |
| 06/09/2005 | US20050123596 pH-triggered microparticles |
| 06/09/2005 | US20050123569 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/09/2005 | US20050123568 Chromatographic purification steps using unbuffered aqueous bases as eluent and subsequent neutralization; low side effect for specific immunotherapy of this pollen allergy; reduced immunoglobulin E binding with simultaneous retention of therapeutically relevant T-cell stimulation |
| 06/09/2005 | US20050123563 Lipoparticles comprising proteins, methods of making, and using the same |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123534 Humanised antibodies |
| 06/09/2005 | US20050123533 Prodrugs activated by targeted catalytic proteins |
| 06/09/2005 | US20050123524 Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseases |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123521 Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| 06/09/2005 | US20050123519 nucleotide sequences, expression vectors and host cells, used for increasing the toxicity of insecticidal proteins to mosquitoes |
| 06/09/2005 | US20050123517 Transducing a neuron with a transgene from the pseudotyped retrovirus virion; gene therapy for neurodegenerative diseases; Huntington's, Parkinson's and Alzheimer's Diseases, Amyotrophic Lateral Sclerosis, ataxia, atrophy, prion disease |
| 06/09/2005 | US20050123515 retroviral vectors comprising nucleotide sequences that code envelope proteins, capable of transduction to target site |
| 06/09/2005 | US20050123514 increasing the transfer of ATP-binding cassette (ABC) transporter expressing cells with retroviral vectors, by contacting with verapamil, diltiazem, quinidine, ritonavir and lentiviruses |